# Atosiban

## Tractocile inj 5mL (7.5mg/mL) infusion

| TAH Drug Code      | [ITRA5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ITRA5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Delay imminent preterm birth in pregnant women with regular uterine contractions of at least 30 seconds duration at a rate of >=4 per 30 mins; cervical dilation of 1-3 cm (0-3 for nulliparas) & effacement of >=50%, age >=18 years; gestational age of 24-33 weeks, normal fetal heart rate.                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Premature labour: Adult: Initially, 6.75 mg bolus (as 7.5 mg/mL solution) over 1 minute, immediately followed by continuous infusion (as 0.75 mg/mL solution) of 0.3 mg/min for 3 hr, then 0.1 mg/min for up to 45 hr. Total duration: < or = 48 hr. the maximum dose: 330.75 mg. Stage 1: 0.9mL IV bolus, over 1 minute, total 6.75mg. Stage 2: IV infusion over 3 hours, 24mL/hour, 18mg/hour. Stage 3: IV infusion, 8mL/hour, 6mg/hour. Reconstitution: for infusion: Withdraw 10 mL from a 100-mL bag of NaCl 0.9%, glucose 5% or Ringerâ€™s lactate solution and replace with 10 mL of atosiban concentrate (using 2 vials of 37.5 mg/5 mL solution) to produce a final concentration of 0.75 mg/mL. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Gestation ages <24 weeks or >33 weeks premature rupture of the membranes > 30 weeks of gestation, intrauterine growth retardation & abnormal fetal heart rate, antepartum uterine hemorrhage requiring immediate delivery, eclampsia & severe pre-eclampsia requiring delivery, intrauterine fetal death, suspected intrauterine infection, placenta praevia, abruptio placenta, abnormal or high-risk pregnancy.                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Very common (>10%): nausea. Common (1-10%): headache, dizziness, hot flushes, vomiting, tachycardia, hypotension, inj site reactions, hyperglycemia. Uncommon (0.1%-1%): fever, insomnia, pruritus, rash. Rare (<0.1%): incidental cases of uterine haemorrhage/uterine atony and one case of allergic reaction were reported.                                                                                                                                                                                                                                                                                                                                                                          |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/atosiban-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

